Cytosorbents Co. (NASDAQ:CTSO – Get Rating) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 669,100 shares, a growth of 14.1% from the April 15th total of 586,200 shares. Currently, 1.8% of the company’s stock are sold short. Based on an average daily […]
Cytosorbents Co. (NASDAQ:CTSO – Get Rating) CFO Kathleen P. Bloch bought 10,000 shares of Cytosorbents stock in a transaction dated Wednesday, May 10th. The shares were acquired at an average cost of $3.11 per share, for a total transaction of $31,100.00. Following the completion of the purchase, the chief financial officer now directly owns 43,700 […]
Cytosorbents Co. (NASDAQ:CTSO – Get Rating) – Equities research analysts at Zacks Small Cap decreased their Q2 2023 EPS estimates for Cytosorbents in a research note issued on Thursday, May 4th. Zacks Small Cap analyst T. Kerr now anticipates that the medical research company will post earnings of ($0.12) per share for the quarter, down […]
Cytosorbents Co. (NASDAQ:CTSO – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 586,200 shares, a decrease of 9.0% from the March 31st total of 644,000 shares. Approximately 1.5% of the company’s stock are short sold. Based on […]
Cytosorbents Co. (NASDAQ:CTSO – Get Rating) saw a significant decrease in short interest in April. As of April 15th, there was short interest totalling 586,200 shares, a decrease of 9.0% from the March 31st total of 644,000 shares. Currently, 1.5% of the shares of the company are sold short. Based on an average daily volume […]